Hajar Alemohammad
About
In The Last Decade
Hajar Alemohammad
12 papers receiving 362 citations
Peers
Comparison fields: 5 of 64
- Molecular Biology 194
- Oncology 127
- Immunology 90
- Cancer Research 86
- Infectious Diseases 40
Countries citing papers authored by Hajar Alemohammad
This map shows the geographic impact of Hajar Alemohammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajar Alemohammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajar Alemohammad more than expected).
Fields of papers citing papers by Hajar Alemohammad
This network shows the impact of papers produced by Hajar Alemohammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajar Alemohammad. The network helps show where Hajar Alemohammad may publish in the future.
Co-authorship network of co-authors of Hajar Alemohammad
This figure shows the co-authorship network connecting the top 25 collaborators of Hajar Alemohammad. A scholar is included among the top collaborators of Hajar Alemohammad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajar Alemohammad. Hajar Alemohammad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 29 | |
| 3 | 66 | |
| 4 | 4 | |
| 5 | 38 | |
| 6 | 10 | |
| 7 | 23 | |
| 8 | 65 | |
| 9 | 63 | |
| 10 | 16 | |
| 11 | 47 | |
| 12 | The Alterations of Cellular Signaling Pathways in the Host Cell upon the High Pathogenic Coronaviruses Infection, SARS-CoV and MERS-CoV. What Could Be Expected from the SARS-CoV-2? | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.